Q has gone 170+ innings every year since 2013 and has the overall cleaner injury history in recent years. He at least pitched some this year while Stroman was completely shut down, Stroman also has a history of leg injuries and had a shoulder issue in 2018 plus he recently has a year where he barely topped 100 IP. Q is just the safer bet to me to meet the ~165IP and ~4.25 ERA threshold I’m looking for as the mid rotation starter add (again I think covering innings pitching even mediocre is gonna be a premium in 2021) and think he’ll be cheaper than Stroman (since Stroman is younger and think is just thought of more highly). I just don’t see the upside in Stroman (injury history and profile) that it’s worth paying him. I’d rather go another way. Other guys who I prefer for a fraction of Stroman and you can take 2-3 chances on for Stroman’s money does include Q but also (and these guys carry risk, but again give me 2-3 of them over Stroman) Desclafani, Minor, Nova, Odorizzi, and Richards off the top of my head (haven’t looked at a FA list recently). Give me Q and one of names mentioned for the amount Stroman goes for. Or save some money for building out the offense. Again this is more I just don’t like Stroman for the likely money thing so take a few shots on other guys for the same money or less than me liking any of these guys more than him. Desclafani, Minor, and Nova suck in a non-debatable way. Just resign Lester if you want to throw someone out there to give up 4 runs in 6 innings once a week. Richards has pitched about 200 innings in the last 5 years total. Odorizzi put up a 2.6 fWAR in 2018 and then a 4.3 in 2019, and then only pitched 13 innings in 2020, so not sure why you'd think he's getting significantly less than Stroman. Minor was worth more WAR than Stroman in 2019 and I think he’ll be cheaper. Desclafani undoubtedly sucked this year but the stuff is there (his FB velo was the highest it’s ever been this year), he will be extremely cheap and think he has the parts to be a decent SP. He’d also be the second or third guy brought in and have to earn a spot as the 4/5. Same reasoning for Nova there mostly. And yeah Richards carries risk but his stuff is generally back and he’s intriguing for the 4/5th role. Give me Q back and 1 of those guys for less money along with internal options to fill out the rotation (Adbert/Mills early then Marquez/Abbott during the year). I thought Odorizzi was more 33/34 and not just 30, you’re right that he’ll probably get a decent deal.